11 studies found for:    Open Studies | "von Willebrand Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
Conditions: Hemophilia A;   Hemophilia B;   Von Willebrand's Disease
2 Not yet recruiting Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)
Condition: Von Willebrands Disease
3 Not yet recruiting Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease
Condition: Type 1 Von Willebrand Disease
Interventions: Drug: recombinant von Willebrand factor;   Drug: tranexamic acid
4 Recruiting Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Other: Patients using wilate as standard of care
5 Recruiting Study of Voncento® in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Voncento
6 Recruiting Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Biological: Recombinant von Willebrand Factor (rVWF)
7 Recruiting Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: plasma-derived FVIII/VWF concentrate Fanhdi
8 Recruiting Willebrand International Non-interventional Global Surveillance
Condition: Von Willebrand Disease
9 Recruiting Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients
Condition: Von Willebrand Disease
Intervention: Biological: Alphanate SD/HT
10 Unknown  The Effect of the Nutraceutical "Hemofix" on the Coagulation System
Conditions: Von Willebrand Disease;   Menorrhagia
Intervention: Dietary Supplement: HEMOFIX
11 Unknown  Evaluation of Menses in Congenital Bleeding Disorders
Conditions: Von Willebrand Disease;   Congenital Coagulation Factors Deficiency;   Haemophilia Carriers

Indicates status has not been verified in more than two years